Controlled Substances and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Controlled Substances

Pharmaceutical Manufacturing

Hyman, Phelps & McNamara, P.C. (HP&M) is Pleased to Announce the Addition of Sara M. Keup as the new State Licensing Regulatory Expert for the Firm’s Licensing Practice

FDA Law Blog: Biosimilars

FEBRUARY 5, 2024

Some of the services HP&M offers include: comprehensive regulatory assessments pre-launch licensing support license gap analysis support for new product/company acquisitions, regulatory diligences DEA registrations and state-controlled substance licenses With the complexities of licensure, Sara M. Palmer , Larry K.

Controlled Substances

Controlled Substances Documentation Pharmaceutical Manufacturing Communication

Reinventing the drum: How milling innovations are cutting costs and reducing footprints

Pharmaceutical Technology

NOVEMBER 25, 2022

For pharmaceutical manufacturers and contract manufacturing organizations (CMOs) with containment capabilities, this likely means a distinct advantage over those without. Dedicated manufacturers are investing heavily in these services, powered by client requirements.

Controlled Substances

Controlled Substances Pharmaceutical Manufacturing

Pharmacist Digest

Hyman, Phelps & McNamara, P.C. (HP&M) is Pleased to Announce the Addition of Sara M. Keup as the new State Licensing Regulatory Expert for the Firm’s Licensing Practice

Reinventing the drum: How milling innovations are cutting costs and reducing footprints

Stay Connected